4D Molecular Therapeutics... (FDMT)
NASDAQ: FDMT
· Real-Time Price · USD
4.07
-0.01 (-0.25%)
At close: Jun 26, 2025, 3:59 PM
4.17
2.58%
After-hours: Jun 26, 2025, 07:12 PM EDT
-0.25% (1D)
| Bid | 3.75 |
| Market Cap | 188.31M |
| Revenue (ttm) | 9K |
| Net Income (ttm) | -176.44M |
| EPS (ttm) | -3.18 |
| PE Ratio (ttm) | -1.28 |
| Forward PE | -1.05 |
| Analyst | Buy |
| Ask | 4.18 |
| Volume | 190,886 |
| Avg. Volume (20D) | 576,916 |
| Open | 4.16 |
| Previous Close | 4.08 |
| Day's Range | 3.91 - 4.16 |
| 52-Week Range | 2.23 - 28.93 |
| Beta | 2.83 |
About FDMT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FDMT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FDMT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
4D Molecular Therapeutics Inc. is scheduled to release its earnings on Aug 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-13.91%
4D Molecular Therapeutics shares are trading lower...
Unlock content with
Pro Subscription
5 months ago
-13.77%
4D Molecular Therapeutics shares are trading lower after Leerink Partners and Morgan Stanley cut their respective price targets on the stock.
